1[1]Sane SP, Bhatt AD. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management [J]. J Assoc physicians India, 2000,48:999-1003.
2[2]Odom RB, James WD, Berger TG, et al. Andrew's Diseases of the Skin Clinical Dermatology [M]. 9 th ed. Harcourt Asia: W B Saunders, 2001. 136-139.
3[3]Kaufman DW, Kelly JP. Acetylsalicylic acid and other salicylates in relation to Stevens-Johnson syndrome and toxic epidermal necrolysis [J]. Br J Clin Pharmacol, 2001,51 (2):174-176.
4[4]Ying S, Ho W, Chan HH. Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong[J]. Burns, 2001, 27(4):372-375.
5[5]Paquet P, Paquet F, Al-Saleh W. Immunoregulatory effeetor cells in drug induced toxic epidermal necrolysis [J]. J Am Dermatol,2000,22(5):413-417.
6[6]Andresen M, Boghero Y, Molgo M. Toxic epidermal necrolysis therapy in ICU with intravenous immunglobulins in a case [J].Rev Med Chil. 2000,128( 12):1343-1348.
